CIK 0001782223 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Pyxis Oncology, Inc.
Sign in to watch- Ticker
- PYXS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831160910
- Phone
- (617) 221-9059
- Business address
- 321 HARRISON AVENUE, BOSTON, MA, 02118
- 4 Insider Changes in Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4/A Insider Changes in Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Insider Changes in Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure · Other events
- 4 Insider Changes in Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 424B2 Offering Prospectus
- EFFECT Other Notice of Effectiveness
Page 1 of 18 · 357 filings